Advanced

Skeletal muscle wasting and renewal : a pivotal role of myokine IL-6

Belizário, José E.; Fontes-Oliveira, Cibely C. LU ; Borges, Janaina Padua; Kashiabara, Janete Akemi and Vannier, Edouard (2016) In SpringerPlus 5(1).
Abstract

Adult skeletal tissue is composed of heterogeneous population of cells that constantly self-renew by means of a controlled process of activation and proliferation of tissue-resident stem cells named satellite cells. Many growth factors, cytokines and myokines produced by skeletal muscle cells play critical roles in local regulation of the inflammatory process and skeletal muscle regeneration during different pathological conditions. IL-6 is a pleiotropic cytokine released in large amount during infection, autoimmunity and cancer. Low levels of IL-6 can promote activation of satellite cells and myotube regeneration while chronically elevated production promote skeletal muscle wasting. These distinct effects may be explained by a... (More)

Adult skeletal tissue is composed of heterogeneous population of cells that constantly self-renew by means of a controlled process of activation and proliferation of tissue-resident stem cells named satellite cells. Many growth factors, cytokines and myokines produced by skeletal muscle cells play critical roles in local regulation of the inflammatory process and skeletal muscle regeneration during different pathological conditions. IL-6 is a pleiotropic cytokine released in large amount during infection, autoimmunity and cancer. Low levels of IL-6 can promote activation of satellite cells and myotube regeneration while chronically elevated production promote skeletal muscle wasting. These distinct effects may be explained by a crosstalk of the IL-6/IL-6 receptor and gp130 trans-signaling pathway that oppose to regenerative and anti-inflammatory of the classical IL-6 receptor signaling pathway. Here we discuss on potential therapeutic strategies using monoclonal antibodies to IL-6R for the treatment of skeletal muscle wasting and cachexia. We also highlight on the IL-6/JAK/STAT and FGF/p38αβ MAPK signaling pathways in satellite cell activation and the use of protein kinase inhibitors for tailoring and optimizing satellite cell proliferation during the skeletal muscle renewal. Future investigations on the roles of the IL-6 classical and trans-signaling pathways in both immune and non-immune cells in skeletal muscle tissue will provide new basis for therapeutic approaches to reverse atrophy and degeneration of skeletal muscles in cancer and inflammatory diseases.

(Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Anti-IL-6 receptor monoclonal antibodies, Cancer cachexia, Exercise, IL-6, IL-6/IL-6R/gp130 signaling pathway, Jak/STAT signaling, Satellite cells, Skeletal muscle
in
SpringerPlus
volume
5
issue
1
publisher
Springer
external identifiers
  • Scopus:84969802025
ISSN
2193-1801
DOI
10.1186/s40064-016-2197-2
language
English
LU publication?
yes
id
80334bc2-1d7b-4b8e-bf2b-c6a48a5eed42
date added to LUP
2016-10-12 13:12:43
date last changed
2016-10-13 03:00:02
@misc{80334bc2-1d7b-4b8e-bf2b-c6a48a5eed42,
  abstract     = {<p>Adult skeletal tissue is composed of heterogeneous population of cells that constantly self-renew by means of a controlled process of activation and proliferation of tissue-resident stem cells named satellite cells. Many growth factors, cytokines and myokines produced by skeletal muscle cells play critical roles in local regulation of the inflammatory process and skeletal muscle regeneration during different pathological conditions. IL-6 is a pleiotropic cytokine released in large amount during infection, autoimmunity and cancer. Low levels of IL-6 can promote activation of satellite cells and myotube regeneration while chronically elevated production promote skeletal muscle wasting. These distinct effects may be explained by a crosstalk of the IL-6/IL-6 receptor and gp130 trans-signaling pathway that oppose to regenerative and anti-inflammatory of the classical IL-6 receptor signaling pathway. Here we discuss on potential therapeutic strategies using monoclonal antibodies to IL-6R for the treatment of skeletal muscle wasting and cachexia. We also highlight on the IL-6/JAK/STAT and FGF/p38αβ MAPK signaling pathways in satellite cell activation and the use of protein kinase inhibitors for tailoring and optimizing satellite cell proliferation during the skeletal muscle renewal. Future investigations on the roles of the IL-6 classical and trans-signaling pathways in both immune and non-immune cells in skeletal muscle tissue will provide new basis for therapeutic approaches to reverse atrophy and degeneration of skeletal muscles in cancer and inflammatory diseases.</p>},
  author       = {Belizário, José E. and Fontes-Oliveira, Cibely C. and Borges, Janaina Padua and Kashiabara, Janete Akemi and Vannier, Edouard},
  issn         = {2193-1801},
  keyword      = {Anti-IL-6 receptor monoclonal antibodies,Cancer cachexia,Exercise,IL-6,IL-6/IL-6R/gp130 signaling pathway,Jak/STAT signaling,Satellite cells,Skeletal muscle},
  language     = {eng},
  month        = {12},
  number       = {1},
  publisher    = {ARRAY(0x62d9910)},
  series       = {SpringerPlus},
  title        = {Skeletal muscle wasting and renewal : a pivotal role of myokine IL-6},
  url          = {http://dx.doi.org/10.1186/s40064-016-2197-2},
  volume       = {5},
  year         = {2016},
}